Glenmark Pharmaceuticals Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Sep '25
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Total Qtr Revenue cr
    6,247.50
    3,290.88
    3,267.89
    3,418.68
    3,473.21
    Other Income Qtr Cr200.6326.4411.6831.1339.42
    Operating Revenues Qtr6,046.873,264.443,256.213,387.553,433.80
    Loading chart...
    Operating Expenses Qtr
    3,687.32
    2,683.92
    2,695.18
    2,787.32
    2,831.88
    Operating Profit Qtr
    2,359.55
    580.52
    561.02
    600.23
    601.91
    EBITDA Qtr Cr
    1,175.06
    283.73
    199.89
    631.36
    641.33
    Depreciation Qtr
    141.20
    129.93
    125.20
    122.74
    120.28
    Net Profit Qtr
    610.35
    46.87
    4.65
    347.96
    354.21
    Basic EPS Qtr
    21.63
    1.66
    0.16
    12.33
    12.55
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -